Abevmy 400 Mg - 16ml Injection

Get Latest Price

Brand Name :

Abevmy

In Stock

Product Specifications

Dosage	400mg
Volume	16ml
Form	Injection
Route	IV Infusion
Packaging	Single Vial
Origin	r-DNA
Manufacturer	Mylan
Features	Targeted Therapy, Cancer Treatment, IV Infusion, Single Dose, Convenient Use, Effective Drug

Product Overview

Key Features

Company Details

Business Type

Exporter, Importer, Supplier, Trading Company, Wholesaler

Employee Count

Establishment

2018

Working Days

Monday To Sunday

GST NO

07AAHCC9138R1ZV

Payment Mode

Letter of Credit (L/C)

Explore Related Categories

Bevacizumab Injection

More Products From This Seller

Seller Details

Connectlife Pharma Private Limited

GST - 07AAHCC9138R1ZV

Rating

New Delhi, Delhi

Director

Mr Amar Keshri

Address

Unit No-119 Dlf Tower B, Jasola Distric Center, Near Apollo Hospital, New Delhi, Delhi, 110025, India

Report incorrect details

Compare With Similar Products

Product Name

Abevmy 400 Mg

Bevacizumab injection

Cizumab 100mg Injection

Buyer Feedback

Price Or Price Range

100.00 - 1000.00 USD ($) (Approx.)

40000 INR (Approx.)

Minimum Order Quantity

2 Bottle/Bottles

1 Pack/Packs

Drug Type

Specific Drug

Injection

Ingredients

Bevacizumab

Physical Form

Liquid

Function

Anti-Cancer

Other

Recommended For

ANTI CANCER

Doctor

Dosage

100mg,400mg

As recommend by doctor

Dosage Guidelines

as direct by physician

Cizumab is prescription drug and should be used under proper medical guidelines and advice.

Quantity

1000 Unit

1 Vial Unit

Storage Instructions

Store in a refrigerator (2 - 8AdegC). Do not freeze.

Store in cool dry place.

Payment Terms

Telegraphic Transfer (T/T)

Cash on Delivery (COD), Telegraphic Transfer (T/T), Others, Cash in Advance (CID)

Packaging Details

BOX OR BOXES PACKING

1 X 1 Vial

Main Export Market(s)

Australia, Eastern Europe, Western Europe, Middle East, Central America, South America, Asia, North America, Africa

Australia, North America, Eastern Europe, Central America, Middle East, South America, Western Europe, Asia, Africa

Main Domestic Market

Assam, Dadra and Nagar Haveli, Chandigarh, Himachal Pradesh, Nagaland, Pondicherry, Uttarakhand, Daman and Diu, Lakshadweep, , South India, East India, Andaman and Nicobar Islands, Andhra Pradesh, Arunachal Pradesh, Bihar, Delhi, Gujarat, Goa, Haryana, Jammu and Kashmir, Jharkhand, Madhya Pradesh, Maharashtra, Mizoram, Meghalaya, Manipur, Punjab, Rajasthan, Sikkim, Telangana, Tripura, West Bengal, Uttar Pradesh, Tamil Nadu, Karnataka, North India, Kerala, Central India, Odisha, West India, Chhattisgarh, All India

All India

Sold By

Connectlife Pharma Private Limited
New Delhi, Delhi